APO Research
Talk to an analyst

APO RESEARCH · REPORT

Stable Isotope Labeled Biomolecules

This report studies the Stable Isotope Labeled Biomolecules market, Stable Isotope Labeled Biomolecules refer to the biomolecule which is labeled by replacing specific atoms by their isotope, and then the reactant is then allowed to undergo the reaction.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

This report studies the Stable Isotope Labeled Biomolecules market, Stable Isotope Labeled Biomolecules refer to the biomolecule which is labeled by replacing specific atoms by their isotope, and then the reactant is then allowed to undergo the reaction.

An important tool for high-resolution structure determination for NMR spectroscopy is the use of stable isotopically labeled biomolecules. By either selectively or uniformly incorporating stable isotopes into proteins, the user is able to significantly reduce the complexity of their spectra. D Labeled Biomolecules, 15N, and deuterium are the most common isotopes incorporated into proteins. Microbial expression systems, cell-free extracts, peptide synthesis and custom synthesis provide a variety of options for accomplishing the incorporation of the labels. Microbial expression systems are cell-based protein expression systems in which the microbes are grown in either a defined or complex media with D Labeled Biomolecules labeled glucoses and 15N Labeled Biomoleculeslabeled ammonium salts as the sole sources of carbon and nitrogen respectively. Ease of use, adaptability and high protein yields have made these expression systems the most popular technique for stable isotope incorporation. Cell-free extracts and custom synthesis also present their own individual advantages with the use of uniformly or selectively labeled amino acids. Cell-free extracts allow the user to more readily implement high-throughput in vitro protein expression as many proteins are difficult to express in vivo due to complications such as toxicity. Custom synthesis allows for unique, site-specific incorporation of isotopes into peptides allowing the user to study distinct structural regions.

Selected research

Market Structure

Global Stable Isotope Labeled Biomolecules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchStable Isotope Labeled Biomolecules Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Stable Isotope Labeled Biomolecules Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Stable Isotope Labeled Biomolecules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Stable Isotope Labeled Biomolecules Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Stable Isotope Labeled Biomolecules Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

This report studies the Stable Isotope Labeled Biomolecules market, Stable Isotope Labeled Biomolecules refer to the biomolecule which is labeled by replacing specific atoms by their isotope, and then the reactant is then allowed to undergo the reaction.

An important tool for high-resolution structure determination for NMR spectroscopy is the use of stable isotopically labeled biomolecules. By either selectively or uniformly incorporating stable isotopes into proteins, the user is able to significantly reduce the complexity of their spectra. D Labeled Biomolecules, 15N, and deuterium are the most common isotopes incorporated into proteins. Microbial expression systems, cell-free extracts, peptide synthesis and custom synthesis provide a variety of options for accomplishing the incorporation of the labels. Microbial expression systems are cell-based protein expression systems in which the microbes are grown in either a defined or complex media with D Labeled Biomolecules labeled glucoses and 15N Labeled Biomoleculeslabeled ammonium salts as the sole sources of carbon and nitrogen respectively. Ease of use, adaptability and high protein yields have made these expression systems the most popular technique for stable isotope incorporation. Cell-free extracts and custom synthesis also present their own individual advantages with the use of uniformly or selectively labeled amino acids. Cell-free extracts allow the user to more readily implement high-throughput in vitro protein expression as many proteins are difficult to express in vivo due to complications such as toxicity. Custom synthesis allows for unique, site-specific incorporation of isotopes into peptides allowing the user to study distinct structural regions.

The major players in global Stable Isotope Labeled Biomolecules market include Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy about 90% of the global market. 13C Labeled Biomolecules is the main type, with a share about 50%. Medical is the main application, which holds a share about 50%.

Read the full market overview

This report provides an overview of the global Stable Isotope Labeled Biomolecules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Stable Isotope Labeled Biomolecules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Stable Isotope Labeled Biomolecules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Stable Isotope Labeled Biomolecules market size, projected growth trends, production technologies, key applications, and end-use industries.

Stable Isotope Labeled Biomolecules Segment by Company

Cambridge Isotope Laboratories

Sigma-Aldrich

Thermo Fisher Scientific

LGC Standards

Toronto Research Chemicals

IsoLife

WITEGA Laboratorien

Omicron Biochemicals

Icon Isotopes

Medical Isotopes

Stable Isotope Labeled Biomolecules Segment by Type

D Labeled Biomolecules

15N Labeled Biomolecules

13C Labeled Biomolecules

Others

Stable Isotope Labeled Biomolecules Segment by Application

Scientific Research

Medical

Industrial

Others

Stable Isotope Labeled Biomolecules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stable Isotope Labeled Biomolecules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Stable Isotope Labeled Biomolecules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stable Isotope Labeled Biomolecules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Stable Isotope Labeled Biomolecules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Stable Isotope Labeled Biomolecules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Stable Isotope Labeled Biomolecules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Stable Isotope Labeled Biomolecules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Stable Isotope Labeled Biomolecules Industry Trends Table 2. Stable Isotope Labeled Biomolecules Industry Drivers Table 3. Stable Isotope Labeled Biomolecules Industry Opportunities and Challenges Table 4. Stable Isotope Labeled Biomolecules Industry Restraints Table 5. Global Stable Isotope Labeled Biomolecules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Stable Isotope Labeled Biomolecules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Stable Isotope Labeled Biomolecules Sales by Manufacturers (g) & (2021-2026) Table 8. Global Stable Isotope Labeled Biomolecules Sales Market Share by Manufacturers Table 9. Global Stable Isotope Labeled Biomolecules Average Sales Price (US$/g) of Manufacturers (2021-2026) Table 10. Global Stable Isotope Labeled Biomolecules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Stable Isotope Labeled Biomolecules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Stable Isotope Labeled Biomolecules Manufacturers, Product Type & Application Table 13. Global Stable Isotope Labeled Biomolecules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Stable Isotope Labeled Biomolecules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of D Labeled Biomolecules Table 17. Major Manufacturers of 15N Labeled Biomolecules Table 18. Major Manufacturers of 13C Labeled Biomolecules Table 19. Major Manufacturers of Others Table 20. Global Stable Isotope Labeled Biomolecules Sales by Type 2021 VS 2025 VS 2032 (g) Table 21. Global Stable Isotope Labeled Biomolecules Sales by Type (2021-2026) & (g) Table 22. Global Stable Isotope Labeled Biomolecules Sales by Type (2027-2032) & (g) Table 23. Global Stable Isotope Labeled Biomolecules Sales Market Share by Type (2021-2026) Table 24. Global Stable Isotope Labeled Biomolecules Sales Market Share by Type (2027-2032) Table 25. Global Stable Isotope Labeled Biomolecules Revenue by Type 2021 VS 2025 VS 2032 (g) Table 26. Global Stable Isotope Labeled Biomolecules Revenue by Type (2021-2026) & (g) Table 27. Global Stable Isotope Labeled Biomolecules Revenue by Type (2027-2032) & (g) Table 28. Global Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2021-2026) Table 29. Global Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Scientific Research Table 31. Major Manufacturers of Medical Table 32. Major Manufacturers of Industrial Table 33. Major Manufacturers of Others Table 34. Global Stable Isotope Labeled Biomolecules Sales by Application 2021 VS 2025 VS 2032 (g) Table 35. Global Stable Isotope Labeled Biomolecules Sales by Application (2021-2026) & (g) Table 36. Global Stable Isotope Labeled Biomolecules Sales by Application (2027-2032) & (g) Table 37. Global Stable Isotope Labeled Biomolecules Sales Market Share by Application (2021-2026) Table 38. Global Stable Isotope Labeled Biomolecules Sales Market Share by Application (2027-2032) Table 39. Global Stable Isotope Labeled Biomolecules Revenue by Application 2021 VS 2025 VS 2032 (g) Table 40. Global Stable Isotope Labeled Biomolecules Revenue by Application (2021-2026) & (g) Table 41. Global Stable Isotope Labeled Biomolecules Revenue by Application (2027-2032) & (g) Table 42. Global Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2021-2026) Table 43. Global Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2027-2032) Table 44. Global Stable Isotope Labeled Biomolecules Sales by Region: 2021 VS 2025 VS 2032 (g) Table 45. Global Stable Isotope Labeled Biomolecules Sales by Region (2021-2026) & (g) Table 46. Global Stable Isotope Labeled Biomolecules Sales Market Share by Region (2021-2026) Table 47. Global Stable Isotope Labeled Biomolecules Sales Forecasted by Region (2027-2032) & (g) Table 48. Global Stable Isotope Labeled Biomolecules Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (g) Table 50. North America Stable Isotope Labeled Biomolecules Sales by Country (2021-2026) & (g) Table 51. North America Stable Isotope Labeled Biomolecules Sales by Country (2027-2032) & (g) Table 52. Europe Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (g) Table 53. Europe Stable Isotope Labeled Biomolecules Sales by Country (2021-2026) & (g) Table 54. Europe Stable Isotope Labeled Biomolecules Sales by Country (2027-2032) & (g) Table 55. Asia Pacific Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (g) Table 56. Asia Pacific Stable Isotope Labeled Biomolecules Sales by Country (2021-2026) & (g) Table 57. Asia Pacific Stable Isotope Labeled Biomolecules Sales by Country (2027-2032) & (g) Table 58. South America, Middle East and Africa Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (g) Table 59. South America, Middle East and Africa Stable Isotope Labeled Biomolecules Sales by Country (2021-2026) & (g) Table 60. South America, Middle East and Africa Stable Isotope Labeled Biomolecules Sales by Country (2027-2032) & (g) Table 61. Global Stable Isotope Labeled Biomolecules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Stable Isotope Labeled Biomolecules Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Stable Isotope Labeled Biomolecules Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2021-2026) Table 65. Global Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2027-2032) Table 66. Cambridge Isotope Laboratories Company Information Table 67. Cambridge Isotope Laboratories Business Overview Table 68. Cambridge Isotope Laboratories Stable Isotope Labeled Biomolecules Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Cambridge Isotope Laboratories Stable Isotope Labeled Biomolecules Product Portfolio Table 70. Cambridge Isotope Laboratories Recent Development Table 71. Sigma-Aldrich Company Information Table 72. Sigma-Aldrich Business Overview Table 73. Sigma-Aldrich Stable Isotope Labeled Biomolecules Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sigma-Aldrich Stable Isotope Labeled Biomolecules Product Portfolio Table 75. Sigma-Aldrich Recent Development Table 76. Thermo Fisher Scientific Company Information Table 77. Thermo Fisher Scientific Business Overview Table 78. Thermo Fisher Scientific Stable Isotope Labeled Biomolecules Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Thermo Fisher Scientific Stable Isotope Labeled Biomolecules Product Portfolio Table 80. Thermo Fisher Scientific Recent Development Table 81. LGC Standards Company Information Table 82. LGC Standards Business Overview Table 83. LGC Standards Stable Isotope Labeled Biomolecules Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. LGC Standards Stable Isotope Labeled Biomolecules Product Portfolio Table 85. LGC Standards Recent Development Table 86. Toronto Research Chemicals Company Information Table 87. Toronto Research Chemicals Business Overview Table 88. Toronto Research Chemicals Stable Isotope Labeled Biomolecules Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Toronto Research Chemicals Stable Isotope Labeled Biomolecules Product Portfolio Table 90. Toronto Research Chemicals Recent Development Table 91. IsoLife Company Information Table 92. IsoLife Business Overview Table 93. IsoLife Stable Isotope Labeled Biomolecules Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. IsoLife Stable Isotope Labeled Biomolecules Product Portfolio Table 95. IsoLife Recent Development Table 96. WITEGA Laboratorien Company Information Table 97. WITEGA Laboratorien Business Overview Table 98. WITEGA Laboratorien Stable Isotope Labeled Biomolecules Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. WITEGA Laboratorien Stable Isotope Labeled Biomolecules Product Portfolio Table 100. WITEGA Laboratorien Recent Development Table 101. Omicron Biochemicals Company Information Table 102. Omicron Biochemicals Business Overview Table 103. Omicron Biochemicals Stable Isotope Labeled Biomolecules Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Omicron Biochemicals Stable Isotope Labeled Biomolecules Product Portfolio Table 105. Omicron Biochemicals Recent Development Table 106. Icon Isotopes Company Information Table 107. Icon Isotopes Business Overview Table 108. Icon Isotopes Stable Isotope Labeled Biomolecules Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Icon Isotopes Stable Isotope Labeled Biomolecules Product Portfolio Table 110. Icon Isotopes Recent Development Table 111. Medical Isotopes Company Information Table 112. Medical Isotopes Business Overview Table 113. Medical Isotopes Stable Isotope Labeled Biomolecules Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Medical Isotopes Stable Isotope Labeled Biomolecules Product Portfolio Table 115. Medical Isotopes Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Stable Isotope Labeled Biomolecules Distributors List Table 119. Stable Isotope Labeled Biomolecules Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Stable Isotope Labeled Biomolecules Product Image Figure 2. Global Stable Isotope Labeled Biomolecules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Stable Isotope Labeled Biomolecules Market Size (2021-2032) & (US$ Million) Figure 4. Global Stable Isotope Labeled Biomolecules Sales (2021-2032) & (g) Figure 5. Global Stable Isotope Labeled Biomolecules Average Price (US$/g) & (2021-2032) Figure 6. Global Top 5 and 10 Stable Isotope Labeled Biomolecules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. D Labeled Biomolecules Image Figure 9. 15N Labeled Biomolecules Image Figure 10. 13C Labeled Biomolecules Image Figure 11. Others Image Figure 12. Global Stable Isotope Labeled Biomolecules Sales by Type (2021 VS 2025 VS 2032) & (g) Figure 13. Global Stable Isotope Labeled Biomolecules Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Stable Isotope Labeled Biomolecules Sales Market Share by Type (2021-2032) Figure 15. Global Stable Isotope Labeled Biomolecules Revenue by Type (2021 VS 2025 VS 2032) & (g) Figure 16. Global Stable Isotope Labeled Biomolecules Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2021-2032) Figure 18. Scientific Research Image Figure 19. Medical Image Figure 20. Industrial Image Figure 21. Others Image Figure 22. Global Stable Isotope Labeled Biomolecules Sales by Application (2021 VS 2025 VS 2032) & (g) Figure 23. Global Stable Isotope Labeled Biomolecules Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Stable Isotope Labeled Biomolecules Sales Market Share by Application (2021-2032) Figure 25. Global Stable Isotope Labeled Biomolecules Revenue by Application (2021 VS 2025 VS 2032) & (g) Figure 26. Global Stable Isotope Labeled Biomolecules Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2021-2032) Figure 28. North America Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 29. North America Stable Isotope Labeled Biomolecules Sales Market Share by Country (2021-2032) Figure 30. U.S. Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 31. Canada Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 32. Mexico Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 33. Europe Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 34. Europe Stable Isotope Labeled Biomolecules Sales Market Share by Country (2021-2032) Figure 35. Germany Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 36. France Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 37. U.K. Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 38. Italy Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 39. Netherlands Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 40. Asia Pacific Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 41. Asia Pacific Stable Isotope Labeled Biomolecules Sales Market Share by Country (2021-2032) Figure 42. China Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 43. Japan Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 44. South Korea Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 45. Southeast Asia Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 46. India Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 47. Australia Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 48. South America, Middle East and Africa Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 49. South America, Middle East and Africa Stable Isotope Labeled Biomolecules Sales Market Share by Country (2021-2032) Figure 50. Brazil Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 51. South Africa Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 52. Saudi Arabia Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 53. Turkey Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 54. Argentina Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 55. UAE Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 56. Egypt Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 57. Chile Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (g) Figure 58. Global Stable Isotope Labeled Biomolecules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Stable Isotope Labeled Biomolecules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Figure 61. North America Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Figure 63. Europe Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Stable Isotope Labeled Biomolecules Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Stable Isotope Labeled Biomolecules Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • D Labeled Biomolecules
  • 15N Labeled Biomolecules
  • 13C Labeled Biomolecules
  • Others
Applications
  • Scientific Research
  • Medical
  • Industrial
  • Others
Companies covered
  • Cambridge Isotope Laboratories
  • Sigma-Aldrich
  • Thermo Fisher Scientific
  • LGC Standards
  • Toronto Research Chemicals
  • IsoLife
  • WITEGA Laboratorien
  • Omicron Biochemicals
  • Icon Isotopes
  • Medical Isotopes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Stable Isotope Labeled Biomolecules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Stable Isotope Labeled Biomolecules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Stable Isotope Labeled Biomolecules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Stable Isotope Labeled Biomolecules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Stable Isotope Labeled Biomolecules Market Dynamics
  1. 2.1 Stable Isotope Labeled Biomolecules Industry Trends
  2. 2.2 Stable Isotope Labeled Biomolecules Industry Drivers
  3. 2.3 Stable Isotope Labeled Biomolecules Industry Opportunities and Challenges
  4. 2.4 Stable Isotope Labeled Biomolecules Industry Restraints
3 Stable Isotope Labeled Biomolecules Market by Manufacturers
  1. 3.1 Global Stable Isotope Labeled Biomolecules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Stable Isotope Labeled Biomolecules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Stable Isotope Labeled Biomolecules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Stable Isotope Labeled Biomolecules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Stable Isotope Labeled Biomolecules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Stable Isotope Labeled Biomolecules Manufacturers, Product Type & Application
  7. 3.7 Global Stable Isotope Labeled Biomolecules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Stable Isotope Labeled Biomolecules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Stable Isotope Labeled Biomolecules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Stable Isotope Labeled Biomolecules Tier 1, Tier 2, and Tier 3
4 Stable Isotope Labeled Biomolecules Market by Type
  1. 4.1 Stable Isotope Labeled Biomolecules Type Introduction
  2. 4.1.1 D Labeled Biomolecules
  3. 4.1.2 15N Labeled Biomolecules
  4. 4.1.3 13C Labeled Biomolecules
  5. 4.1.4 Others
  6. 4.2 Global Stable Isotope Labeled Biomolecules Sales by Type
  7. 4.2.1 Global Stable Isotope Labeled Biomolecules Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Stable Isotope Labeled Biomolecules Sales by Type (2021-2032)
  9. 4.2.3 Global Stable Isotope Labeled Biomolecules Sales Market Share by Type (2021-2032)
  10. 4.3 Global Stable Isotope Labeled Biomolecules Revenue by Type
  11. 4.3.1 Global Stable Isotope Labeled Biomolecules Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Stable Isotope Labeled Biomolecules Revenue by Type (2021-2032)
  13. 4.3.3 Global Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2021-2032)
5 Stable Isotope Labeled Biomolecules Market by Application
  1. 5.1 Stable Isotope Labeled Biomolecules Application Introduction
  2. 5.1.1 Scientific Research
  3. 5.1.2 Medical
  4. 5.1.3 Industrial
  5. 5.1.4 Others
  6. 5.2 Global Stable Isotope Labeled Biomolecules Sales by Application
  7. 5.2.1 Global Stable Isotope Labeled Biomolecules Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Stable Isotope Labeled Biomolecules Sales by Application (2021-2032)
  9. 5.2.3 Global Stable Isotope Labeled Biomolecules Sales Market Share by Application (2021-2032)
  10. 5.3 Global Stable Isotope Labeled Biomolecules Revenue by Application
  11. 5.3.1 Global Stable Isotope Labeled Biomolecules Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Stable Isotope Labeled Biomolecules Revenue by Application (2021-2032)
  13. 5.3.3 Global Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2021-2032)
6 Global Stable Isotope Labeled Biomolecules Sales by Region
  1. 6.1 Global Stable Isotope Labeled Biomolecules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Stable Isotope Labeled Biomolecules Sales by Region (2021-2032)
  3. 6.2.1 Global Stable Isotope Labeled Biomolecules Sales by Region (2021-2026)
  4. 6.2.2 Global Stable Isotope Labeled Biomolecules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Stable Isotope Labeled Biomolecules Revenue by Region
  1. 7.1 Global Stable Isotope Labeled Biomolecules Revenue by Region
  2. 7.1.1 Global Stable Isotope Labeled Biomolecules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Stable Isotope Labeled Biomolecules Revenue by Region (2021-2026)
  4. 7.1.3 Global Stable Isotope Labeled Biomolecules Revenue by Region (2027-2032)
  5. 7.1.4 Global Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Stable Isotope Labeled Biomolecules Revenue (2021-2032)
  8. 7.2.2 North America Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Stable Isotope Labeled Biomolecules Revenue (2021-2032)
  11. 7.3.2 Europe Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Stable Isotope Labeled Biomolecules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Stable Isotope Labeled Biomolecules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Cambridge Isotope Laboratories
  2. 8.1.1 Cambridge Isotope Laboratories Company Information
  3. 8.1.2 Cambridge Isotope Laboratories Business Overview
  4. 8.1.3 Cambridge Isotope Laboratories Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Cambridge Isotope Laboratories Stable Isotope Labeled Biomolecules Product Portfolio
  6. 8.1.5 Cambridge Isotope Laboratories Recent Developments
  7. 8.2 Sigma-Aldrich
  8. 8.2.1 Sigma-Aldrich Company Information
  9. 8.2.2 Sigma-Aldrich Business Overview
  10. 8.2.3 Sigma-Aldrich Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sigma-Aldrich Stable Isotope Labeled Biomolecules Product Portfolio
  12. 8.2.5 Sigma-Aldrich Recent Developments
  13. 8.3 Thermo Fisher Scientific
  14. 8.3.1 Thermo Fisher Scientific Company Information
  15. 8.3.2 Thermo Fisher Scientific Business Overview
  16. 8.3.3 Thermo Fisher Scientific Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thermo Fisher Scientific Stable Isotope Labeled Biomolecules Product Portfolio
  18. 8.3.5 Thermo Fisher Scientific Recent Developments
  19. 8.4 LGC Standards
  20. 8.4.1 LGC Standards Company Information
  21. 8.4.2 LGC Standards Business Overview
  22. 8.4.3 LGC Standards Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 LGC Standards Stable Isotope Labeled Biomolecules Product Portfolio
  24. 8.4.5 LGC Standards Recent Developments
  25. 8.5 Toronto Research Chemicals
  26. 8.5.1 Toronto Research Chemicals Company Information
  27. 8.5.2 Toronto Research Chemicals Business Overview
  28. 8.5.3 Toronto Research Chemicals Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Toronto Research Chemicals Stable Isotope Labeled Biomolecules Product Portfolio
  30. 8.5.5 Toronto Research Chemicals Recent Developments
  31. 8.6 IsoLife
  32. 8.6.1 IsoLife Company Information
  33. 8.6.2 IsoLife Business Overview
  34. 8.6.3 IsoLife Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 IsoLife Stable Isotope Labeled Biomolecules Product Portfolio
  36. 8.6.5 IsoLife Recent Developments
  37. 8.7 WITEGA Laboratorien
  38. 8.7.1 WITEGA Laboratorien Company Information
  39. 8.7.2 WITEGA Laboratorien Business Overview
  40. 8.7.3 WITEGA Laboratorien Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 WITEGA Laboratorien Stable Isotope Labeled Biomolecules Product Portfolio
  42. 8.7.5 WITEGA Laboratorien Recent Developments
  43. 8.8 Omicron Biochemicals
  44. 8.8.1 Omicron Biochemicals Company Information
  45. 8.8.2 Omicron Biochemicals Business Overview
  46. 8.8.3 Omicron Biochemicals Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Omicron Biochemicals Stable Isotope Labeled Biomolecules Product Portfolio
  48. 8.8.5 Omicron Biochemicals Recent Developments
  49. 8.9 Icon Isotopes
  50. 8.9.1 Icon Isotopes Company Information
  51. 8.9.2 Icon Isotopes Business Overview
  52. 8.9.3 Icon Isotopes Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Icon Isotopes Stable Isotope Labeled Biomolecules Product Portfolio
  54. 8.9.5 Icon Isotopes Recent Developments
  55. 8.10 Medical Isotopes
  56. 8.10.1 Medical Isotopes Company Information
  57. 8.10.2 Medical Isotopes Business Overview
  58. 8.10.3 Medical Isotopes Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Medical Isotopes Stable Isotope Labeled Biomolecules Product Portfolio
  60. 8.10.5 Medical Isotopes Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Stable Isotope Labeled Biomolecules Value Chain Analysis
  2. 9.1.1 Stable Isotope Labeled Biomolecules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Stable Isotope Labeled Biomolecules Production Mode & Process
  6. 9.2 Stable Isotope Labeled Biomolecules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Stable Isotope Labeled Biomolecules Distributors
  9. 9.2.3 Stable Isotope Labeled Biomolecules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst